Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 2, 1998, Pages 185-189

  Bardhan, K D ^a   Morton, D ^a   Slater, D N ^a   Perry, M J ^a   Cherian, P ^a   Jones, R B ^a   Brookes, A ^a   Thompson, M ^a   Morris, P ^a   McCaldin, B ^b  

^a Rotherham NHS Foundation Trust   (United Kingdom)

^b Scicom   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; PANTOPRAZOLE; TINIDAZOLE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CHRONIC GASTRITIS; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DUODENUM ULCER; FEMALE; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH EROSION; TASTE DISORDER; THORAX PAIN;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ANTITRICHOMONAL AGENTS; BENZIMIDAZOLES; CLARITHROMYCIN; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PILOT PROJECTS; STOMACH ULCER; SULFOXIDES; TINIDAZOLE; TREATMENT OUTCOME;

EID: 15644379238     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00276.x     Document Type: Article

References (17)

1. Huber R, Kohl B, Sachs G, Senn-Beifinger J, Simon WA, Sturm E. The continuing development of PPI with particular reference to pantoprazole. Aliment Pharmacol Ther 1995; 9: 336-78.
2. Fytton A, Wikman L. Pantoprazole: A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996; 51: 3460-82.
3. Moayyedi P, Sahay P, Tompkind DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40.
4. Louw JA, Marks IN, van Rensburg CJ, Jaskiewicz K, Thron I, Bethke TH. The effect of pantoprazole, as monotherapy and in combination with amoxicillin, on gastric H. pylori status, in duodenal ulcer subjects. Gut 1994; 35(Suppl. 2): S63.
5. Moayyedi P, Tompkins DS, Axon ATR. Ellicacy of ten days clarithromycin, amoxycillin and omeprazole in eradicating Helicobacter infection. Gut 1995; 37(Suppl. 1): A44 (Abstract).
6. Hunt RH, Malfertheiner P, Yeomans ND, Hawkey CJ, Howden CW. Meeting Report: Critical issues in the pathophysiology and management of peptic ulcer disease. Eur J Gastroenterol Hepatol 1995; 7: 685-99. (From an International Workshop. 'Critical issues in the era of the PPI's' 24-26 November 1994.)
7. Jaup BH, Norrby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90(6): 943-5.
8. Misiewicz JJ, Tytgat GNJ, Goodwill CSA. et al. The Sydney system: a new classification for gastritis. Working Party Reports; 1990 World Congress of Gastroenterology 26-31 August. Sydney. Australia: Blackwell Scientific Publications, pp 1-10. (Published as a supplement to J Gastroenterol Hepatol.)
9. Lind T, Veldhuyen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH1 study. Helicobacter 1996; 1: 138-44.
10. Bazzoli F, Zagari RM, Pfaffenback B, Opferkuch W, Ricken D. Short-term low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
11. Labenz J, Peitz U, Tillenburg B, Becker T, Börsch G, Stolle M. Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for eradication of Helicobacter pylori. Leber Magen Darm 1995; 25: 122-7.
12. Adamek RJ, Szymanski C, Pfaffenback B, Opferkuch W, Ricken D. Modified short-term triple therapy with pantoprazole, clarithromycin and metronidazole for cure of Helicobacter infection. Dtsch Med Wschr 1995; 120: 358-60.
13. Penston JG. Review article: Helicobacter eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-89.
14. Walsh JH, Peterson WL. The treatment of Helicobacter pylori in the management of peptic ulcer disease. New Eng J Med 1995; 333: 984-91.
15. Mégraude F, Lehn N, Lind T, et al. The MACH2 study. Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome. Gastroenterology 1997; 112: A216 (Abstract).
16. Karim QN, Logan RPH. The epidemiology of Helicobacter (H. pylori) antimicrobial resistance - preliminary findings of a national survey. Gut 1995: 37(Suppl. 2): A6 (Abstract W22).
17. Penston JG. Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996; 10: 469-86.